Centiva Capital’s Lyell Immunopharma LYEL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,108	Closed	-$30.6K	–	1624
2024 Q3	$30.6K	Buy	+1,108	New	+$30.6K	﹤0.01%	1462
2023 Q4	–	Sell	-973	Closed	-$28.6K	–	1491
2023 Q3	$28.6K	Buy	+973	New	+$28.6K	﹤0.01%	1144